Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
- 1 March 2016
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 38 (3) , 603-609
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With StatinsJACC, 2015
- Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority TrialClinical Therapeutics, 2014
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsCirculation, 2014
- Letter by Jones et al Regarding Article, “Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation”Circulation, 2014
- Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without InflammationCirculation, 2013
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart DiseaseJACC, 2013
- Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 TrialJACC, 2008
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Cholesterol Profile Measurement by Vertical Auto Profile MethodClinics In Laboratory Medicine, 2006
- Elevated Remnant-Like Particle Cholesterol ConcentrationCirculation, 2004